LIDOSITE TOPICAL SYSTEM KIT (epinephrine; lidocaine hydrochloride) by AstraZeneca is impulses, presumably by increasing the threshold for electrical excitation in the nerve, by slowing the propagation of the nerve impulse, and by reducing the rate of rise of the action potential. Approved for regional anesthesia, analgesia for surgery, dental and 4 more indications. First approved in 2004.
Drug data last refreshed 16h ago · AI intelligence enriched 1mo ago
LIDOSITE is a topical anesthetic patch combining lidocaine hydrochloride and epinephrine, delivered via iontophoresis for rapid local anesthesia. It blocks nerve impulses by increasing electrical excitation thresholds and slowing impulse propagation, with epinephrine serving as a vasoconstrictor to prolong drug residence time. Indicated for regional anesthesia, procedural analgesia, and pain relief in dental, oral surgery, diagnostic, therapeutic, and obstetrical procedures.
Product approaching loss of exclusivity with moderate competitive pressure (30), indicating potential team downsizing and transition to lifecycle management strategies.
impulses, presumably by increasing the threshold for electrical excitation in the nerve, by slowing the propagation of the nerve impulse, and by reducing the rate of rise of the action potential. In general, the progression of anesthesia is related to the diameter, myelination, and conduction…
Worked on LIDOSITE TOPICAL SYSTEM KIT at AstraZeneca? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
LIDOSITE offers limited career growth opportunity as a LOE-approaching product with zero linked job openings, making it a defensive rather than expansive assignment. Roles on this franchise typically focus on profitability protection, generic contingency planning, and transition to lifecycle management rather than innovation-driven work.